Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B
- 24 June 1985
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 57 (3) , 257-262
- https://doi.org/10.1016/0304-3940(85)90501-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effectsLife Sciences, 1985
- II. Selective accumulation of MPP+ in the substantia nigra: A key to neurotoxicity?Life Sciences, 1985
- V. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983
- Different stereoselective inhibition of monoamine oxidase-B by the R- and S-enantiomers of MD 780236Journal of Pharmacy and Pharmacology, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- The deamination of dopamine by human brain monoamine oxidaseNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1983